Fermenta Biotech [FERMENTA] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Fermenta Biotech wins in 15 metrics, Innova Captab wins in 3 metrics, with 0 ties. Fermenta Biotech appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricFermenta BiotechInnova CaptabBetter
P/E Ratio (TTM)9.1337.44Fermenta Biotech
Price-to-Book Ratio2.665.07Fermenta Biotech
Debt-to-Equity Ratio32.0635.24Fermenta Biotech
PEG Ratio-0.027.14Fermenta Biotech
EV/EBITDA7.1226.94Fermenta Biotech
Profit Margin (TTM)19.81%9.98%Fermenta Biotech
Operating Margin (TTM)16.45%11.68%Fermenta Biotech
EBITDA Margin (TTM)16.45%11.68%Fermenta Biotech
Return on Equity21.44%13.37%Fermenta Biotech
Return on Assets (TTM)12.51%8.12%Fermenta Biotech
Free Cash Flow (TTM)$187.69M$-1.09BFermenta Biotech
Dividend Yield0.71%N/AN/A
1-Year Return2.71%16.46%Innova Captab
Price-to-Sales Ratio (TTM)1.813.74Fermenta Biotech
Enterprise Value$10.03B$51.37BInnova Captab
EV/Revenue Ratio1.903.95Fermenta Biotech
Gross Profit Margin (TTM)65.48%37.21%Fermenta Biotech
Revenue per Share (TTM)$181$227Innova Captab
Earnings per Share (Diluted)$35.83$22.70Fermenta Biotech
Beta (Stock Volatility)-0.16N/AN/A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Fermenta Biotech vs Innova Captab Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Fermenta Biotech-4.24%0.34%-8.40%-1.87%23.06%-17.75%
Innova Captab0.35%0.46%-4.62%-2.11%-0.23%-24.99%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Fermenta Biotech2.71%61.94%-8.27%70.06%70.06%70.06%
Innova Captab16.46%53.72%53.72%53.72%53.72%53.72%

News Based Sentiment: Fermenta Biotech vs Innova Captab

Fermenta Biotech

News based Sentiment: POSITIVE

Fermenta Biotech’s Q3 FY24 results demonstrate significant revenue and profit growth, driven by its Vitamin D3 business. The company’s commitment to sustainability further enhances its long-term investment appeal, making this a noteworthy month for investors.

View Fermenta Biotech News Sentiment Analysis

Innova Captab

News based Sentiment: POSITIVE

Innova Captab reported impressive revenue and profit growth for both Q1 FY2026 and the full fiscal year 2025-26, supported by a 'Buy' rating from JM Financial. While there were shifts in shareholding, particularly a decrease in FII holdings, the overall narrative points towards a positive trajectory for the company.

View Innova Captab News Sentiment Analysis

Performance & Financial Health Analysis: Fermenta Biotech vs Innova Captab

MetricFERMENTAINNOVACAP
Market Information
Market Cap i₹9.82B₹48.64B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i24,18533,824
90 Day Avg. Volume i29,84940,665
Last Close₹308.45₹835.20
52 Week Range₹219.00 - ₹449.00₹662.00 - ₹1,260.00
% from 52W High-31.30%-33.71%
All-Time High₹449.00 (Feb 10, 2025)₹1,260.00 (Jan 06, 2025)
% from All-Time High-31.30%-33.71%
Growth Metrics
Quarterly Revenue Growth0.74%0.20%
Quarterly Earnings Growth0.74%0.05%
Financial Health
Profit Margin (TTM) i0.20%0.10%
Operating Margin (TTM) i0.16%0.12%
Return on Equity (TTM) i0.21%0.13%
Debt to Equity (MRQ) i32.0635.24
Cash & Liquidity
Book Value per Share (MRQ)₹123.23₹167.66
Cash per Share (MRQ)₹24.01₹11.41
Operating Cash Flow (TTM) i₹-59,490,000₹282.88M
Levered Free Cash Flow (TTM) i₹768.62M₹1.28B
Dividends
Last 12-Month Dividend Yield i0.71%N/A
Last 12-Month Dividend i₹2.50N/A

Valuation & Enterprise Metrics Analysis: Fermenta Biotech vs Innova Captab

MetricFERMENTAINNOVACAP
Price Ratios
P/E Ratio (TTM) i9.1337.44
Forward P/E iN/A20.01
PEG Ratio i-0.027.14
Price to Sales (TTM) i1.813.74
Price to Book (MRQ) i2.665.07
Market Capitalization
Market Capitalization i₹9.82B₹48.64B
Enterprise Value i₹10.03B₹51.37B
Enterprise Value Metrics
Enterprise to Revenue i1.903.95
Enterprise to EBITDA i7.1226.94
Risk & Other Metrics
Beta i-0.16N/A
Book Value per Share (MRQ) i₹123.23₹167.66

Financial Statements Comparison: Fermenta Biotech vs Innova Captab

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)FERMENTAINNOVACAP
Revenue/Sales i₹1.36B₹3.52B
Cost of Goods Sold i₹470.43M₹2.21B
Gross Profit i₹892.20M₹1.31B
Research & Development iN/AN/A
Operating Income (EBIT) i₹224.21M₹410.54M
EBITDA i₹370.04M₹565.82M
Pre-Tax Income i₹280.87M₹426.77M
Income Tax i₹64.85M₹116.62M
Net Income (Profit) i₹216.02M₹310.15M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)FERMENTAINNOVACAP
Cash & Equivalents i₹282.40M₹155.19M
Total Current Assets i₹3.35B₹7.03B
Total Current Liabilities i₹2.12B₹3.53B
Long-Term Debt i₹194.91M₹2.45B
Total Shareholders Equity i₹3.59B₹9.59B
Retained Earnings i₹3.25B₹4.53B
Property, Plant & Equipment i₹2.16B₹442.93M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)FERMENTAINNOVACAP
Operating Cash Flow iN/A₹378.60M
Capital Expenditures iN/A₹-1.21B
Free Cash Flow iN/A₹-908.56M
Debt Repayment iN/A₹-7.69M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricFERMENTAINNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i24,18533,824
Average Daily Volume (90 Day) i29,84940,665
Shares Outstanding i29.17M57.22M
Float Shares i8.54M15.70M
% Held by Insiders i0.70%0.72%
% Held by Institutions i0.00%0.19%

Dividend Analysis & Yield Comparison: Fermenta Biotech vs Innova Captab

MetricFERMENTAINNOVACAP
Last 12-Month Dividend i₹2.50N/A
Last 12-Month Dividend Yield i0.71%N/A
3-Year Avg Annual Dividend i₹0.83N/A
3-Year Avg Dividend Yield i0.71%N/A
3-Year Total Dividends i₹2.50N/A
Ex-Dividend DateAug 06, 2025N/A